Bookmark

Add to MyYahoo RSS

Acura Pharmaceuticals News

News on Acura Pharmaceuticals (Ticker: ACUR) continually updated from thousands of sources around the net.

Friday Apr 11 | Seeking Alpha

Acura Pharmaceuticals' CEO Presents at Return of Product Rights Conference

Good morning, ladies and gentlemen, and welcome to the Acura Pharmaceuticals announcing Return of Product Rights Conference Call.

Comment?

Related Topix: Biotech

Thu Apr 10, 2014

MarketWatch

Acura Pharmaceuticals ends Pfizer licensing pact

Acura said it regained the product rights to the Oxecta pain drug, and it would pay Pfizer $2 million under the termination agreement.

Comment?

Related Topix: Biotech, Medicine, Health, Pain

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••